Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Coffee, Renal Oxygenation, Blood Flow and Glomerular Filtration Rate in Early Diabetic Kidney Disease.

NCT03878277 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT03878277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03878277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Coffee, Renal Oxygenation, Blood Flow and Glomerular Filtration Rate in Early Diabetic Kidney Disease.
Lead sponsor
University of Colorado, Denver
Phase
Phase 2
Overall status
Completed
Start date
July 1, 2019
Completion date
September 30, 2021
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes complications, diabetes, autoimmune, diabetic kidney disease, diabetic nephropathies, juvenile diabetes, type1 diabetes mellitus, type1diabetes